Adial PharmaceuticalsADIL
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 15 institutions reported holding Adial Pharmaceuticals Inc. (ADIL) in their 13F filings, unchanged from Q1 2024. 4 opened new positions and 4 sold out. The largest holders were UBS Group AG ($96K), Manchester Capital Management LLC ($55K) and Renaissance Technologies ($39K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Adial Pharmaceuticals Inc.
- CUSIP
- 00688A205
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $63K |
| Exits | 4 | $30K |
All 13F filers, Q1 2024 → Q2 2024: 153,950 shares bought and 46,337 shares sold, net +107,613 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| UBS Group AG | 0.00% | Add +1360.1% | 83,605 | $96K |
| Manchester Capital Management LLC | 0.01% | No change | 48,097 | $55K |
| Renaissance Technologies | 0.00% | Reduce -32.8% | 34,346 | $39K |
| HRT Financial LP | 0.00% | Reduce -18.3% | 29,228 | $33K |
| BlackRock Inc. | 0.00% | Add +263.5% | 27,770 | $32K |
| Geode Capital Management, LLC | 0.00% | New | 25,874 | $30K |
| Citadel Advisors | 0.00% | New | 24,746 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +21.8% | 5,632 | $6K |
| 1620 Investment Advisors, Inc. | 0.00% | New | 3,600 | $4K |
| Bank of America Corp. | 0.00% | New | 689 | $792 |
| Morgan Stanley | 0.00% | Add +160.0% | 39 | $45 |
| Abound Wealth Management | 0.00% | No change | 27 | $32 |
| Qube Research & Technologies Ltd | 0.00% | No change | 8 | $10 |
| Royal Bank of Canada | 0.00% | No change | 19 | $0 |
| Benjamin F. Edwards & Company, Inc. | 0.00% | No change | 40 | $0 |
"% of holder's portfolio" is ADIL's weight in each manager's 13F, not the share of Adial Pharmaceuticals Inc. the manager owns.